Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Mascola

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Methods in Molecular Medicine|March 8, 2011
Neutralization of HIV-1 Infection of Human Peripheral Blood Mononuclear Cells (PBMC) : Antibody Dilution MethodJ R Mascola
Methods in Molecular Medicine|March 8, 2011
Neutralization of HIV-1 Infection of Human Peripheral Blood Mononuclear Cells (PBMC) : Infectivity Reduction MethodJ R Mascola
JAMA|August 4, 1999
Herpes simplex virus vaccines--why don't antibodies protect?J R Mascola
The Journal of Infectious Diseases|December 1, 1995
Human immunodeficiency virus type 1 candidate vaccine breakthrough infectionJ R Mascola, J G McNeil
Reviews of Infectious Diseases|September 1, 1991
Infectious causes of carpal tunnel syndrome: case report and reviewJ R Mascola, L S Rickman
Methods in Molecular Medicine|March 8, 2011
Determination of Syncytium-Inducing Phenotype of Primary HIV-1 Isolates Using MT-2 cellsM K Louder, J R Mascola
Methods in Molecular Medicine|March 8, 2011
Determination of HIV-1 Chemokine Coreceptor Tropism Using Transduced Human Osteosarcoma (HOS) CellsM K Louder, J R Mascola
AIDS Research and Human Retroviruses|December 1, 1993
Antigen detection in neutralization assays: high levels of interfering anti-p24 antibodies in some plasmaJ R Mascola, D S Burke
Current Opinion in Immunology|August 11, 2001
Vaccines for the prevention of HIV-1 diseaseJ R Mascola, G J Nabel
AIDS (London, England)|November 22, 2000
HIV-1 entry at the mucosal surface: role of antibodies in protectionJ R Mascola, S S Frankel, K Broliden
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Methods in Molecular Medicine|March 8, 2011
Neutralization of HIV-1 Infection of Human Peripheral Blood Mononuclear Cells (PBMC) : Antibody Dilution MethodJ R Mascola
Methods in Molecular Medicine|March 8, 2011
Neutralization of HIV-1 Infection of Human Peripheral Blood Mononuclear Cells (PBMC) : Infectivity Reduction MethodJ R Mascola
JAMA|August 4, 1999
Herpes simplex virus vaccines--why don't antibodies protect?J R Mascola
The Journal of Infectious Diseases|December 1, 1995
Human immunodeficiency virus type 1 candidate vaccine breakthrough infectionJ R Mascola, J G McNeil
Reviews of Infectious Diseases|September 1, 1991
Infectious causes of carpal tunnel syndrome: case report and reviewJ R Mascola, L S Rickman
Methods in Molecular Medicine|March 8, 2011
Determination of Syncytium-Inducing Phenotype of Primary HIV-1 Isolates Using MT-2 cellsM K Louder, J R Mascola
Methods in Molecular Medicine|March 8, 2011
Determination of HIV-1 Chemokine Coreceptor Tropism Using Transduced Human Osteosarcoma (HOS) CellsM K Louder, J R Mascola
AIDS Research and Human Retroviruses|December 1, 1993
Antigen detection in neutralization assays: high levels of interfering anti-p24 antibodies in some plasmaJ R Mascola, D S Burke
Current Opinion in Immunology|August 11, 2001
Vaccines for the prevention of HIV-1 diseaseJ R Mascola, G J Nabel
AIDS (London, England)|November 22, 2000
HIV-1 entry at the mucosal surface: role of antibodies in protectionJ R Mascola, S S Frankel, K Broliden
Pageof 6